enGene Therapeutics ENGN
NASDAQ ENGN
$1.94 -0.04 (-2.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Property, Plant & Equipment (Net) (2022 - 2026)

Updated

enGene Therapeutics' Property, Plant & Equipment (Net) was $2.16 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 14.7% from $1.88 million a year earlier but down 7.7% from the prior quarter.

Analysis

enGene Therapeutics (ENGN) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends

At the end of FY2025 (ended Oct 31, 2025), Property, Plant & Equipment (Net) at enGene Therapeutics came in at $2.48 million, up 111.9% from FY2024.

  • Property, Plant & Equipment (Net) has now increased for three consecutive fiscal years, with a three-year compound annual growth rate of 85.7% (FY2022 to FY2025).
  • In earlier fiscal years, Property, Plant & Equipment (Net) was $1.17 million in FY2024 (+98.5%), $589,000 in FY2023 (+52.2%) and $387,000 in FY2022.
  • Quarterly Property, Plant & Equipment (Net) has moved between $387,000 (fiscal Q4 2022) and $2.48 million (fiscal Q4 2025) over five years.
  • Compared with a year earlier, Property, Plant & Equipment (Net) has increased for eight straight quarters, with growth averaging 64.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Property, Plant & Equipment (Net) ranged from 14.7% (fiscal Q3 2026) to 111.9% (fiscal Q4 2025).
  • Per Business Quant data, ENGN's Property, Plant & Equipment (Net) in the three fiscal quarters before Q3 2026 was $2.34 million (Q2 2026), $2.44 million (Q1 2026) and $2.48 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 enGene Therapeutics 130.01 Mn 130.01 Mn - 2.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 2.16 Mn
Apr 30, 2026 2.34 Mn
Jan 31, 2026 2.44 Mn
Oct 31, 2025 2.48 Mn
Jul 31, 2025 1.88 Mn
Apr 30, 2025 1.55 Mn
Jan 31, 2025 1.37 Mn
Oct 31, 2024 1.17 Mn
Jul 31, 2024 1.01 Mn
Apr 30, 2024 1.11 Mn
Jan 31, 2024 993,000.00
Oct 31, 2023 589,000.00
Oct 31, 2022 387,000.00
API Access

enGene Therapeutics Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=ENGN&period=max&api_key=YOUR_API_KEY